Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Hinz, Michael Dr. (1) Scheidereit, Claus Prof. Dr. (1) Stein, Ulrike Prof. Dr. (1) Walther, Wolfgang Prof. Dr. (1) Wollert-Wulf, Brigitte (1) (-) Janz, Martin Dr. (5) (-) Mathas, Stephan Dr. (7) (-) Biologie maligner Lymphome (9) Molekulare Immunologie und Gentherapie (20) Systembiologie von Gen-regulatorischen Elementen (1) Translationale Onkologie solider Tumore (1) 1999 (1) (-) 2000 (1) 2001 (1) 2002 (5) (-) 2003 (3) 2004 (3) 2005 (3) 2006 (5) 2007 (4) 2008 (4) 2009 (4) 2010 (3) 2011 (4) 2012 (2) 2013 (3) 2014 (2) (-) 2015 (5) 2016 (3) 2017 (5) 2018 (1) 2019 (2) 2020 (6) 2021 (3) 2022 (7) 2023 (10) 2024 (2) 9 Ergebnisse: Active Filter: Janz, Martin Dr.Mathas, Stephan Dr.Biologie maligner Lymphome200020032015 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Januar 2003 / J Biol Chem YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression K. Juerchott S. Bergmann U. Stein W. Walther M. Janz I. Manni G. Piaggio E. Fietze M. Dietel H.D. Royer 01. August 2003 / Blood Inhibition of NF-κB essentially contributes to arsenic-induced apoptosis S. Mathas A. Lietz M. Janz M. Hinz F. Jundt C. Scheidereit K. Bommert B. Doerken 01. Mai 2003 / Blood Macrophage inflammatory protein 1-alpha (MIP-1alpha) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells S. Lentzsch M. Gries M. Janz R. Bargou B. Doerken M.Y. Mapara 01. Juni 2015 / Front Biosci The origins of ALK translocations V. Roukos S. Mathas 01. Januar 2000 / Canc Res Anti-CD20-and B-cell receptor-mediated apoptosis: Evidence for shared intracellular signaling pathways S. Mathas A. Rickers K. Bommert B. Doerken M.Y. Mapara 11. April 2015 / Lancet Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial K. Behringer H. Goergen F. Hitz J.M. Zijlstra R. Greil J. Markova S. Sasse M. Fuchs M.S. Topp M. Soekler S. Mathas J. Meissner M. Wilhelm P. Koch H.W. Lindemann E. Schalk R. Semrau J. Kriz T. Vieler M. Bentz E. Lange R. Mahlberg A. Hassler M. Vogelhuber D. Hahn J. Mezger S.W. Krause N. Skoetz B. Böll B. von Tresckow V. Diehl M. Hallek P. Borchmann H. Stein H. Eich A. Engert 01. Januar 2015 / Blood Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma A. Weilemann M. Grau T. Erdmann O. Merkel U. Sobhiafshar I. Anagnostopoulos M. Hummel A. Siegert C. Hayford H. Madle B. Wollert-Wulf I. Fichtner B. Dörken S. Dirnhofer S. Mathas M. Janz N.C.T. Emre A. Rosenwald G. Ott P. Lenz A. Tzankov G. Lenz 01. Mai 2015 / Leukemia The IL-15 cytokine system provides growth and survival signals in hodgkin lymphoma and enhances the inflammatory phenotype of HRS cells K. Ullrich F. Blumenthal-Barby B. Lamprecht K. Koechert D. Lenze M. Hummel S. Mathas B. Doerken M. Janz 01. März 2015 / Cytokine Cytokine and proinflammatory gene expression in classical Hodgkin lymphoma: its more than NF-κB! S. Kreher P. Cauchy C. Bonifer S. Mathas
01. Januar 2003 / J Biol Chem YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression K. Juerchott S. Bergmann U. Stein W. Walther M. Janz I. Manni G. Piaggio E. Fietze M. Dietel H.D. Royer
01. August 2003 / Blood Inhibition of NF-κB essentially contributes to arsenic-induced apoptosis S. Mathas A. Lietz M. Janz M. Hinz F. Jundt C. Scheidereit K. Bommert B. Doerken
01. Mai 2003 / Blood Macrophage inflammatory protein 1-alpha (MIP-1alpha) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells S. Lentzsch M. Gries M. Janz R. Bargou B. Doerken M.Y. Mapara
01. Januar 2000 / Canc Res Anti-CD20-and B-cell receptor-mediated apoptosis: Evidence for shared intracellular signaling pathways S. Mathas A. Rickers K. Bommert B. Doerken M.Y. Mapara
11. April 2015 / Lancet Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial K. Behringer H. Goergen F. Hitz J.M. Zijlstra R. Greil J. Markova S. Sasse M. Fuchs M.S. Topp M. Soekler S. Mathas J. Meissner M. Wilhelm P. Koch H.W. Lindemann E. Schalk R. Semrau J. Kriz T. Vieler M. Bentz E. Lange R. Mahlberg A. Hassler M. Vogelhuber D. Hahn J. Mezger S.W. Krause N. Skoetz B. Böll B. von Tresckow V. Diehl M. Hallek P. Borchmann H. Stein H. Eich A. Engert
01. Januar 2015 / Blood Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma A. Weilemann M. Grau T. Erdmann O. Merkel U. Sobhiafshar I. Anagnostopoulos M. Hummel A. Siegert C. Hayford H. Madle B. Wollert-Wulf I. Fichtner B. Dörken S. Dirnhofer S. Mathas M. Janz N.C.T. Emre A. Rosenwald G. Ott P. Lenz A. Tzankov G. Lenz
01. Mai 2015 / Leukemia The IL-15 cytokine system provides growth and survival signals in hodgkin lymphoma and enhances the inflammatory phenotype of HRS cells K. Ullrich F. Blumenthal-Barby B. Lamprecht K. Koechert D. Lenze M. Hummel S. Mathas B. Doerken M. Janz
01. März 2015 / Cytokine Cytokine and proinflammatory gene expression in classical Hodgkin lymphoma: its more than NF-κB! S. Kreher P. Cauchy C. Bonifer S. Mathas